Editorial: Serum IGF-1 linking visceral obesity with esophageal adenocarcinoma: Unconvincing evidence

American Journal of Gastroenterology

Volumn 107, Issue 2, 2012, Pages 205-206

  McColl, K E L ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

BODY MASS; CANCER CELL CULTURE; CARCINOGENESIS; CELL PROLIFERATION; DISEASE ASSOCIATION; ESOPHAGEAL ADENOCARCINOMA; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOHISTOLOGY; INTRAABDOMINAL FAT; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; ADENOCARCINOMA; ESOPHAGUS TUMOR; FEMALE; MALE; METABOLISM; NOTE; SQUAMOUS CELL CARCINOMA;

ADENOCARCINOMA; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; OBESITY; RECEPTOR, IGF TYPE 1;

EID: 84856736763     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2011.421     Document Type: Review

References (8)

1. Lagergren J, Bergstrom R, Lindgren A et al. Symptomatic gastroesophageal reflux as a risk factor foresophageal adenocarcinoma. New Engl J Med 1999; 340: 825-31. (Pubitemid 29142625)
2. Derakhshan MH, Robertson EV, Fletcher J et al. Mechanism of association between BMI and dysfunction of the gastro-oesophageal barrier in patients with normal endoscopy. Gut 2011. Online First published on 28 August 2011 as 10.1136/gutjnl-2011-300633.
3. Doyle SL, Donohoe CL, Finn SP et al. IGF-1 and its receptor in esophageal cancer: association withadenocarcinoma and visceral obesity. Am J Gastroenterol 2012 ;107:196-204 (this issue).
4. Renehan AG, Frystyk J, Flyvbjerg A. Obesity and cancer risk: the role of the insulin-IGF axis. Trends Endocrinol Metab 2006; 17: 328-36. (Pubitemid 44397568)
5. Rowlands M-A, Holly JMP, Gunnell D et al. The relation between adiposity throughout the life course and variation in IGFs and IGFBPs: evidence from the ProtecT (Prostate testing for cancer and Treatment) study. Cancer Causes Control 2010; 21: 1829-42.
6. Frystyk J. Free insulin-like growth factors-measurements and relationships to growth hormone secretion and glucose homeostasis. Growth Horm IGF Res 2004; 14: 337-75. (Pubitemid 39185988)
7. Frystyk J, Vestbo E, Skjaerbaek C et al. Free insulin-like growth factors in human obesity. Metabolism 1995; 44: 37-44.
8. Bergmann U, Funatomi H, Yokoyama M et al. Insulin-like growth factor I overexpression in human pancreatic cancer: evidence for autocrine and paracrine roles. Cancer Res 1995; 55: 2007-11.